Abstract
Our aim was to investigate the long-term effects of intramuscular injection of rAAV2/1-CMV-GH1 viral particles on GH1 expression in normal adult male rats. We found that specific and sustained GH1 expression did not improve muscle exercise performance despite inducing local muscle hypertrophy. Injection of rAAV2/1-CMV-GH1 had some systemic effects on the liver and heart and on lipid metabolism in the healthy rats. Serum levels of hGH (human growth hormone), insulin, glucose and leptin increased significantly, which might induce insulin resistance. The serum concentration of IGF-1 (insulin-like growth factor 1), IGF-BP3 (insulin-like growth factor binding protein 3) and PIIINP (N-terminal propeptide of type III procollagen) markedly increased at 24 weeks after injection of GH1. In conclusion, GH1 expression driven by AAV2/1 in normal animals did not improve muscle strength but did increase muscle mass and may have systemic effects in healthy animals.
Similar content being viewed by others
Abbreviations
- EDL:
-
Extensor digitorum longus muscle
- GH:
-
Growth hormone
- hGH:
-
Human growth hormone
- IGF-1:
-
Insulin-like growth factor 1
- IGF-BP3:
-
Insulin-like growth factor binding protein 3
- MHC:
-
Myosin heavy chain
- PIIINP:
-
N-terminal propeptide of type III procollagen
- rAAV vector:
-
Recombinant adeno-associated virus vector
- rAAV2/1:
-
Recombinant adeno-associated viral vectors pseudotyped with viral capsids from serotype 1
- rtGH:
-
The replacement therapy of GH
- SOL:
-
Soleus muscle
References
Götherström G, Elbornsson M, Stibrant-Sunnerhagen K, Bengtsson BA, Johannsson G, Svensson J (2008) Ten years of growth hormone (GH) replacement normalizes muscle strength in GH deficient adults. J Clin Endocrinol Metab 94:809–816. doi:10.1210/jc.2008-1538
Schweizer R, Martin DD, Schönau E, Ranke MB (2008) Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition. J Clin Endocrinol Metab 93(8):2978–2983. doi:10.1210/jc.2007-2600
Marmary Y, Parlow AF, Goldsmith CM, He X, Wellner RB, Satomura K, Kriete MF, Robey PG, Nieman LK, Baum BJ (1999) Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone. Endocrinology 140:260–265. doi:10.1210/en.140.1.260
Rivera VM, Ye X, Courage NL, Sachar J, Cerasoli F, Wilson JM, Gilman M (1999) Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA 96:8657–8662. doi:10.1073/pnas.96.15.8657
Haisma HJ, de Hon O (2006) Gene doping. Int J Sports Med 27:257–266. doi:10.1055/s-2006-923986
Filipp F (2007) Is science killing sport? Gene therapy and its possible abuse in doping. EMBO Rep 8(5):433–435. doi:10.1038/sj.embor.7400968
Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558–2573. doi:10.1056/NEJMra062453
Ehrnborg C, Rosén T (2008) Physiological and pharmacological basis for the ergogenic effects of growth hormone in elite sports. Asian J Androl 10(3):373–383. doi:10.1111/j.1745-7262.2008.00403.x
Wang JH, Xie J, Lu H, Chen LX, Hauck B, Samulski RJ, Xiao WD (2007) Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci USA 104(32):13104–13109. doi:10.1073/pnas.0702778104
Zhang N, Clément N, Chen N, Fu S, Zhang H, Rebollo P, Linden RM, Bromberg JS (2005) Transduction of pancreatic islets with pseudotyped adeno-associated virus: effect of viral capsid and genome conversion. Transplantation 80(5):683–690. doi:10.1097/01.tp.0000173381.97556.0d
Wells DJ (2008) Gene doping: the hype and the reality. Br J Pharmacol 154(3):623–631. doi:10.1038/bjp.2008.144
Qin Y, Tian YP (2010) Microarray gene analysis of peripheral whole blood in normal adult male rats after chronic GH gene therapy. Cell Mol Biol Lett. doi:10.2478/s11658-010-0001-9
Yan H, Guo YH, Zhang P, Zu LY, Dong XY, Chen L, Tian JW, Fan XL, Wang NP, Wu XB, Gao W (2005) Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. Biochem Biophys Res Commun 336(1):278–287. doi:10.1016/j.bbrc.2005.08.066
Zhang Z, Han L, Liang X, Cao L, Sun W (2009) A PCR based method to construct small interference RNA expression vectors. Mol Biol Rep 36(4):801–805. doi:10.1007/s11033-008-9248-x
Snyder R, Xiao X, Samulski RJ (1996) Production of recombinant adenoassociated viral vectors. In: Smith D (ed) Current protocols in human genetics. Wiley, New York, pp 12.1.1–12.2.23
Prasad S, Singh K (2008) Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging. Mol Biol Rep 35(4):677–684. doi:10.1007/s11033-007-9140-0
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193:265–275
Frier BC, Locke M (2007) Heat stress inhibits skeletal muscle hypertrophy. Cell Stress Chaperon 12(2):132–141. doi:10.1379/CSC-233R.1
Bottinelli R, Canepari M, Pellegrino MA, Reggiani C (1996) Force-velocity properties of human skeletal muscle fibres: myosin heavy chain isoform and temperature dependence. J Physiol 495:573–586
D’Antona G, Pellegrino MA, Adami R, Rossi R, Carlizzi CN, Canepari M, Saltin B, Bottinelli R (2003) The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 552:499–511. doi:10.1113/jphysiol.2003.046276
Denti MA, Rosa A, D’Antona G, Sthandier O, De Angelis FG, Nicoletti C, Allocca M, Pansarasa O, Parente V, Musarò A, Auricchio A, Bottinelli R, Bozzoni I (2006) Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 103(10):3758–3763. doi:10.1073/pnas.0508917103
Danieli Betto D, Zerbato E, Betto R (1986) Type 1, 2A and 2B myosin heavy chain electrophoretic analysis of rat muscle fibers. Biochem Biophys Res Commun 138:981–987. doi:10.1016/S0006-291X(86)80592-7
Stienen GJ, Kiers JL, Botrinelli R, Reggiani C (1996) Myofibrillar ATPase activity in skinned human skeletal muscle fibres: fibre type and temperature dependence. J Physiol 493:299–307
Sasaki TM, Sonnae A (1972) Effect of acetic acid concentration on the color reaction in the otoluidine-boric acid method for blood glucose estimation. Rinsho Kagaku 1:346–353
Warnick GR, Nguyen T, Alberts AA (1985) Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 31:217
Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld W (1985) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 20:1075
Rifai N, Bachorik PS, Alberts JJ (1999) Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. W.B. Saunders Company, Philadelphia, pp 809–861
Friedwald WT, Levy RJ, Fredricken DS (1972) Estimation of HDL-c in the plasma without the use of preparative ultracentrifuge. Clin Chem 18:449
Lai X, Lan X, Chen H, Wang X, Wang K, Wang M, Yu H, Zhao M (2009) A novel SNP of the Hesx1 gene in bovine and its associations with average daily gain. Mol Biol Rep 36(7):1677–1681. doi:10.1007/s11033-008-9368-3
Ren G, Chen H, Zhang LZ, Lan XY, Wei TB, Li MJ, Jing YJ, Lei CZ, Wang JQ (2010) A coding SNP of LHX4 gene is associated with body weight and body length in bovine. Mol Biol Rep 37(1):417–422. doi:10.1007/s11033-009-9486-6
Fang M, Nie Q, Luo C, Zhang D, Zhang X (2010) Associations of GHSR gene polymorphisms with chicken growth and carcass traits. Mol Biol Rep 37(1):423–428. doi:10.1007/s11033-009-9556-9
Adams GR, Mccue SA (1998) Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84:1716–1722
Yang JY, NamPark H, Cha YS (2006) Effects of resistance exercise and growth hormone administration at low doses on lipid metabolism in middle-aged female rats. Eur J Pharmacol 539(1–2):99–107. doi:10.1016/j.ejphar.2006.03.079
Pang WJ, Yu TY, Bai L, Yang YJ, Yang GS (2009) Tissue expression of porcine FoxO1 and its negative regulation during primary preadipocyte differentiation. Mol Biol Rep 36(1):165–176. doi:10.1007/s11033-007-9163-6
Raaijmakers R, Noordam C, Karagiannis C, Gregory JW, Hertel NT, Sipilä I, Otten BJ (2008) Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database. J Pediatr Endocrinol Metab 21(3):267–273
Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE (2000) Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth. Clin Endocrinol 53(3):329–333. doi:10.1046/j.1365-2265.2000.01105.x
Acknowledgments
The authors express gratitude to the staff of the department for their support and suggestions. This work was partly supported by the grants from the National Science Foundation for Post-doctoral Scientists of China to Ying Qin (No. 20080431363) and the National Natural Science Foundation of China to Ya-ping Tian (No. 20635002).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
11033_2010_16_MOESM1_ESM.doc
Table 1. Body weights and organ weights (wet weight) of the rats 24 weeks after the injection of either the rAAV2/1 virus containing the GH1 expression vector, the empty vector or a placebo (saline). * P < 0.05 versus the EV group. (DOC 33 kb)
11033_2010_16_MOESM2_ESM.doc
Table 2. Serum lipid profiles, blood glucose, leptin and insulin 24 weeks after injection. * P < 0.05 and * P < 0.01 versus the EV group. (DOC 32 kb)
Rights and permissions
About this article
Cite this article
Qin, Y., Tian, YP. Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male rats. Mol Biol Rep 37, 3643–3651 (2010). https://doi.org/10.1007/s11033-010-0016-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0016-3